Muscular Dystrophy Campaign Welcomes Landmark Embryology ActCommenting on the new Human Fertilisation and Embryology Act, Director of Policy and Campaigns, Robert Meadowcroft, said: "The Muscular Dystrophy Campaign wholeheartedly welcomes the passing into law of the Human Fertilisation and Embryology Act. The new legislation creates the framework in which vital progress can be made into research of devastating and life-limiting conditions such as muscular dystrophy.
Assisted Reproduction Linked To Higher Birth Defects A nationwide US study found that babies conceived with Assisted Reproductive Technology (ART), such as in vitro fertilization (IVF) were between 2 and 4 times more likely to be born with certain defects than babies conceived naturally. The study was conducted by researchers at the US Centers for Disease Control and Prevention (CDC) and was published early online in the journal Human Reproduction on 16 November.
First Ovary Transplant Woman Gives Birth A 39-year old woman who had the world's first whole ovary transplant gave birth to a healthy daughter in a private London hospital last week after undergoing pioneering new treatment developed in the US that allowed her to receive an ovary donated by her twin sister and then conceive naturally, according to a BBC News report.
Luteal Phase Bleeding Does Not Accurately Predict Ongoing Pregnancy In IVFResearchers from Brigham & Women's Hospital in Boston today presented data demonstrating that women undergoing In Vitro Fertilization (IVF) and using either vaginally-administered progesterone gel (CRINONE® 8%) or progesterone injected intramuscularly for luteal phase supplementation, reported no difference in ongoing pregnancy rates when they experienced luteal phase bleeding (LPB). LPB is defined as any bleeding or spotting between embryo transfer and first pregnancy test.
Royal Assent For Human Fertilisation And Embryology ActNew laws that will help maintain the UK's position as a world leader in embryo research, enable scientists to investigate cures for serious illnesses such as Parkinson's disease and regulate assisted reproductive treatments, received Royal Assent today. The new Human Fertilisation and Embryology Act updates the 1990 law to ensure that it is fit for purpose in the 21st Century and keeps the UK at the forefront of developments in treatment and research.
First At Home Test For Vasectomized Men Proves To Be Safe, AccurateIn a report now available online and scheduled to be the cover story of the December 2008 issue of the Journal of Urology, University of Virginia Health System researcher John C. Herr, PhD and his colleagues have confirmed the accuracy and reliability of SpermCheck Vasectomy, the first FDA approved at-home immunodiagnostic test for detecting low concentrations of sperm.
Research Identifies Predictors For Successful IVFFerring Pharmaceuticals presented the results of a number of studies in assisted reproductive technology (ART) treatments at the 64th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in San Francisco, November 8-12, 2008. Four studies compared ENDOMETRIN(R) (progesterone) Vaginal Insert, 100 mg, to intramuscular (IM) progesterone-in-oil (PIO) for luteal support.
Fertility Experts Present The Latest Research At Reproductive Medicine MeetingLeading fertility experts at NewYork-Presbyterian Hospital/Columbia University Medical Center are presenting new research findings at the 64th annual American Society of Reproductive Medicine (ASRM) meeting in San Francisco, Nov. 8 - 12. Highlights include the following: -- Dr. Mark V. Sauer is chairing the invited symposia, "Management of the HIV-Discordant Couple Seeking Fertility Care." He will speak on "Clinical Paradigms Gained From 10 Years of Experience." -- Dr.
Expert Warns Size Zero Trend Can Cause InfertilityThe UK's obsession with 'size 0' celebrities is causing women to put themselves at risk of infertility, warns leading fertility expert Professor Brian Lieberman. More and more women are shedding the pounds in an attempt to mimic shockingly thin celebrities, without realising that dramatic weight loss can be detrimental to their fertility. Professor Lieberman - credited with the establishment of the UK's first NHS IVF centre and founder of
New Insights Into Thalidomide-birth Defect Episode - Molecular PharmaceuticsScientists in Germany have discovered why the medication thalidomide appeared safe in animal tests before going on the market 50 years ago, only to cause perhaps the most extensive outbreak of drug-induced birth defects in medical history. Their study is scheduled for the December 1 edition of ACS' Molecular Pharmaceutics, a bimonthly journal.